Ronald T C M van Nordennen1, Jan C M Lavrijsen2, Malou J A B Heesterbeek3, Hans Bor2, Kris C P Vissers4, Raymond T C M Koopmans5. 1. Groenhuysen Organisation, Roosendaal, The Netherlands. Electronic address: ronald.vannordennen@radboudumc.nl. 2. Radboud University Medical Centre, Nijmegen, The Netherlands. 3. Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands. 4. Radboudumc Expertise Centre for Pain and Palliative Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands. 5. Radboud University Medical Centre, Nijmegen, The Netherlands; Joachim en Anna, Centre for Specialized Geriatric Care Nijmegen, The Netherlands.
Abstract
BACKGROUND: The aim of prescribing medication in palliative end-of-life care should be symptom control. Data are lacking regarding the prescription of medication at the end of life. AIM: To investigate the prescription of medication in patients at the end of life in palliative care facilities. DESIGN, SETTING, AND PARTICIPANTS: An observational multicenter study in 7 inpatient palliative care facilities. Participants were adults with an estimated life expectancy of less than 3 months. The study was conducted from February 1, 2012, to January 1, 2013. RESULTS: A total of 155 patients were enrolled. On average, patients were prescribed 6.1 drugs at the moment of admission and 4.6 drugs on the day of death. The prescription of analgesics, psycholeptics, and drugs for functional gastrointestinal disorders increased from admission until death. In general, these are drug classes prescribed for symptom control. All other drug classes decreased between admission and the day of death, including different drug classes for the treatment of comorbid disease, such as anticoagulants, beta-blocking agents, drugs used in diabetes, and lipid-modifying agents. CONCLUSIONS AND RELEVANCE: A reduction in the total amount of medication is seen between admission and death in the palliative care facilities. Although there is an increase in prescribed symptom-specific medication and a reduction in medication prescribed for comorbid disease, there are still patients dying with medication not used for symptom control. This increases pill burden and indicates that physicians need to develop guidelines and educational programs for decreasing medication for comorbidities at the end of life.
BACKGROUND: The aim of prescribing medication in palliative end-of-life care should be symptom control. Data are lacking regarding the prescription of medication at the end of life. AIM: To investigate the prescription of medication in patients at the end of life in palliative care facilities. DESIGN, SETTING, AND PARTICIPANTS: An observational multicenter study in 7 inpatient palliative care facilities. Participants were adults with an estimated life expectancy of less than 3 months. The study was conducted from February 1, 2012, to January 1, 2013. RESULTS: A total of 155 patients were enrolled. On average, patients were prescribed 6.1 drugs at the moment of admission and 4.6 drugs on the day of death. The prescription of analgesics, psycholeptics, and drugs for functional gastrointestinal disorders increased from admission until death. In general, these are drug classes prescribed for symptom control. All other drug classes decreased between admission and the day of death, including different drug classes for the treatment of comorbid disease, such as anticoagulants, beta-blocking agents, drugs used in diabetes, and lipid-modifying agents. CONCLUSIONS AND RELEVANCE: A reduction in the total amount of medication is seen between admission and death in the palliative care facilities. Although there is an increase in prescribed symptom-specific medication and a reduction in medication prescribed for comorbid disease, there are still patients dying with medication not used for symptom control. This increases pill burden and indicates that physicians need to develop guidelines and educational programs for decreasing medication for comorbidities at the end of life.
Authors: Bregje A A Huisman; Eric C T Geijteman; Jimmy J Arevalo; Marianne K Dees; Lia van Zuylen; Karolina M Szadek; Agnes van der Heide; Monique A H Steegers Journal: BMC Palliat Care Date: 2021-07-16 Impact factor: 3.234